Is Anaptysbio Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: ANAB) stock is to Buy ANAB stock.
Out of 3 analysts, 1 (33.33%) are recommending ANAB as a Strong Buy, 0 (0%) are recommending ANAB as a Buy, 2 (66.67%) are recommending ANAB as a Hold, 0 (0%) are recommending ANAB as a Sell, and 0 (0%) are recommending ANAB as a Strong Sell.
What is ANAB's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: ANAB) forecast ROE is N/A, which is considered weak.
What is ANAB's Price Target?
According to 3 Wall Street analysts that have issued a 1 year ANAB price target, the average ANAB price target is $33.67, with the highest ANAB stock price forecast at $45.00 and the lowest ANAB stock price forecast at $26.00.
On average, Wall Street analysts predict that Anaptysbio's share price could reach $33.67 by Aug 8, 2024. The average Anaptysbio stock price prediction forecasts a potential upside of 99.57% from the current ANAB share price of $16.87.
What is ANAB's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: ANAB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.